John A. Auchampach, PhD
Principal Investigator; Professor, Vice Chair, Pharmacology and Toxicology
Dr. Auchampach is a professor in the Department of Pharmacology. He leads an NIH-funded laboratory focused on ischemic heart disease, cardiac regeneration, and drug development.
Tina Wan, PhD
Our laboratory studies adenosine signaling via its four G protein-coupled receptors during cardiovascular disease. We utilize mice and rats as our model system. I am involved in generating and characterizing new genetic mouse models with global and tissue-specific deletion of specific adenosine receptor subtypes. Other important aspects of my research involve assessing cardiac function (pressure-volume analyses; echocardiography) and conducting surgeries to induce myocardial infarction in rodents. Our laboratory has recently formed a new collaboration with Dr. John Lough in the Department of Cell Biology. The goal of this project using novel genetic mouse models is to test the hypothesis that inhibition of the acetyl transferase Tip60 during myocardial infarction will promote more efficient regeneration by permitting surviving cardiomyocytes to re-enter the cell cycle.
Elizabeth Gizewski, BS
Research Technologist III
I received my Degree from the University of Wisconsin-Madison. I have been working with Dr. Auchampach’s research group for the past 10 years. My role has been to characterize new synthetic ligands for adenosine receptors utilizing various biochemical assays including radioligand binding, cAMP accumulation, and [35S]GTPγS binding assays. I have made several important contributions to our research program working with research chemists at the NIH and Leiden University in the Netherlands. I have assisted with the development of new selective agonists for the A3 adenosine receptor, which have promise as drug therapy for many different inflammatory disorders and chronic neuropathic pain. I have also contributed to the development and characterization of an exciting new class of ligands for the A3 adenosine receptor called positive A3 adenosine receptor allosteric modulators.
Shraddha Nayak, BS
Graduate Research Assistant
I am a PhD graduate student in the Department of Pharmacology completing my thesis work in Dr. Auchampach’s laboratory. My project involves characterizing a new line of rats in which the A2B adenosine receptor gene has been genetically disrupted using the zinc finger nuclease strategy. The rat line was created on the Dahl salt-sensitive genetic background. My work has led to better understanding of the participation of A2B adenosine receptor signaling during cardiovascular diseases including hypertension and diabetes.
(Wan TC, Tampo A, Kwok WM, Auchampach JA.) Biochem Pharmacol. 2019 05;163:21-31 PMID: 30710517 PMCID: PMC6470012 SCOPUS ID: 2-s2.0-85061006338 02/03/2019
(Tosh DK, Rao H, Bitant A, Salmaso V, Mannes P, Lieberman DI, Vaughan KL, Mattison JA, Rothwell AC, Auchampach JA, Ciancetta A, Liu N, Cui Z, Gao ZG, Reitman ML, Gavrilova O, Jacobson KA.) J Med Chem. 2019 Feb 14;62(3):1502-1522 PMID: 30605331 PMCID: PMC6467784 SCOPUS ID: 2-s2.0-85059756838 01/04/2019
(Wodsedalek DJ, Paddock SJ, Wan TC, Auchampach JA, Kenarsary A, Tsaih SW, Flister MJ, O'Meara CC.) Am J Physiol Heart Circ Physiol. 2019 01 01;316(1):H24-H34 PMID: 30339498 SCOPUS ID: 2-s2.0-85060194313 10/20/2018
(Yu J, Mannes P, Jung YH, Ciancetta A, Bitant A, Lieberman DI, Khaznadar S, Auchampach JA, Gao ZG, Jacobson KA.) Medchemcomm. 2018 Nov 01;9(11):1920-1932 PMID: 30568760 PMCID: PMC6256369 12/21/2018
(Tosh DK, Ciancetta A, Mannes P, Warnick E, Janowsky A, Eshleman AJ, Gizewski E, Brust TF, Bohn LM, Auchampach JA, Gao ZG, Jacobson KA.) ACS Omega. 2018 Oct 31;3(10):12658-12678 PMID: 30411015 PMCID: PMC6210068 11/10/2018
(Carlin JL, Jain S, Duroux R, Suresh RR, Xiao C, Auchampach JA, Jacobson KA, Gavrilova O, Reitman ML.) Neuropharmacology. 2018 09 01;139:268-278 PMID: 29548686 PMCID: PMC6067974 SCOPUS ID: 2-s2.0-85043451256 03/20/2018
(Du L, Gao ZG, Paoletta S, Wan TC, Gizewski ET, Barbour S, van Veldhoven JPD, IJzerman AP, Jacobson KA, Auchampach JA.) Purinergic Signal. 2018 03;14(1):59-71 PMID: 29170977 PMCID: PMC5842153 SCOPUS ID: 2-s2.0-85034734757 11/25/2017
(Duroux R, Ciancetta A, Mannes P, Yu J, Boyapati S, Gizewski E, Yous S, Ciruela F, Auchampach JA, Gao ZG, Jacobson KA.) Medchemcomm. 2017 Aug 01;8(8):1659-1667 PMID: 29250307 PMCID: PMC5729930 12/19/2017
(Tosh DK, Janowsky A, Eshleman AJ, Warnick E, Gao ZG, Chen Z, Gizewski E, Auchampach JA, Salvemini D, Jacobson KA.) J Med Chem. 2017 04 13;60(7):3109-3123 PMID: 28319392 PMCID: PMC5501184 SCOPUS ID: 2-s2.0-85017530793 03/21/2017
(Densmore JC, Schaid TR, Jeziorczak PM, Medhora M, Audi S, Nayak S, Auchampach J, Dwinell MR, Geurts AM, Jacobs ER.) Exp Lung Res. 2017 02;43(1):38-48 PMID: 28266889 PMCID: PMC5831175 SCOPUS ID: 2-s2.0-85014510215 03/08/2017
(Duroux R, Ciancetta A, Mannes P, Yu J, Boyapati S, Gizewski E, Yous S, Ciruela F, Auchampach JA, Gao ZG, Jacobson KA.) MedChemComm. 2017;8(8):1659-1667 SCOPUS ID: 2-s2.0-85027529790 01/01/2017
(Duroux R, Ciancetta A, Mannes P, Yu J, Boyapati S, Gizewski E, Yous S, Ciruela F, Auchampach JA, Gao ZG, Jacobson KA.) Med Chem Commun. 2017 June 20;8: 1659-1667 06/20/2017